The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...

New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...

An innovative new treatment for tackling some of the toughest stomach cancers has shown promise in a phase 2 clinical trial, ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs ...

Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary ...

Ichnos Glenmark Innovation's ISB 2001 has shown promising results in treating relapsed or refractory multiple myeloma (RRMM), ...